Grant: CIHR Fellowship
Direct Payment
$129,167.00
Molecular mechanism of cysteine catalysis by mammalian enzyme cysteine dioxygenase implicated in Parkinson's, Alzheimer's and other neurodegenerative diseases.
EF 2011-12
Résumé
Elevated levels of iron and cysteine have been long implicated in a number of neurodegenerative diseases (NDD), including Alzheimer's and Parkinson's, the latter affecting 2% of all people over the age of 65. A reduced activity of cysteine dioxygenase (CDO) has been reported in patients suffering NDD. CDO is an iron-dependent enzyme conducting the prime step within cysteine metabolism. The fact that intracellular CDO concentration is tightly linked to cysteine levels through the ubiquitination pathway and that a genetic basis for CDO deficiency has yet to be reported illustrate the current lack of an explanation of the etiology of this disease, which warrants biochemical and biophysical investigation of CDO catalysis. This strategy could possibly provide a mechanistic basis for reduced CDO activity in the context of NDD.
Our experiments will generate the kinetic and spectroscopic evidence to explain the role of iron in catalysis by CDO. Understanding the mechanisms by which the build-up of iron and cysteine occurs is essential for effective treatment of Parkinson's and other neurodegenerative diseases. This knowledge is fundamental to advances in understanding CDO's activity and role in health and disease.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
New Zealand
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
242797
Name
Tchesnokov Egor P
Country
New Zealand
Orgtype
Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Molecular mechanism of cysteine catalysis by mammalian enzyme cysteine dioxygenase implicated in Parkinson's, Alzheimer's and other neurodegenerative diseases.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$129,167
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Chemistry Of Neurodegenerative Diseases; Cysteine Dioxygenase; Enzyme Kinetics; Mass Spectrometry; Mössbauer Spectroscopy; Non-Heme Mono-Iron(Ii) Protein; Rapid Stop Flow; Reaction Intermediates; Resonance Raman Spectroscopy; Ultra Rapid Freeze-Quench
Abstract
Elevated levels of iron and cysteine have been long implicated in a number of neurodegenerative diseases (NDD), including Alzheimer's and Parkinson's, the latter affecting 2% of all people over the age of 65. A reduced activity of cysteine dioxygenase (CDO) has been reported in patients suffering NDD. CDO is an iron-dependent enzyme conducting the prime step within cysteine metabolism. The fact that intracellular CDO concentration is tightly linked to cysteine levels through the ubiquitination pathway and that a genetic basis for CDO deficiency has yet to be reported illustrate the current lack of an explanation of the etiology of this disease, which warrants biochemical and biophysical investigation of CDO catalysis. This strategy could possibly provide a mechanistic basis for reduced CDO activity in the context of NDD.
Our experiments will generate the kinetic and spectroscopic evidence to explain the role of iron in catalysis by CDO. Understanding the mechanisms by which the build-up of iron and cysteine occurs is essential for effective treatment of Parkinson's and other neurodegenerative diseases. This knowledge is fundamental to advances in understanding CDO's activity and role in health and disease.
Competitiondate
201110
Approvedterm2
2 yrs 7 mths
Pinamesdelim
Tchesnokov, Egor P
Approvedterm
2 ans 7 mois
Cihrcontribution2
~ $129,167~ $0~